Authors:
Bromidge, SM
Griffith, K
Heightman, TD
Jennings, A
King, FD
Moss, SF
Newman, H
Riley, G
Routledge, C
Serafinowska, HT
Thomas, DR
Citation: Sm. Bromidge et al., Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT6 receptor, BIOORG MED, 11(21), 2001, pp. 2843-2846
Authors:
Bromidge, SM
Clarke, SE
Gager, T
Griffith, K
Jeffrey, P
Jennings, AJ
Joiner, GF
King, FD
Lovell, PJ
Moss, SF
Newman, H
Riley, G
Rogers, D
Routledge, C
Serafinowska, H
Smith, DR
Citation: Sm. Bromidge et al., Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134), BIOORG MED, 11(1), 2001, pp. 55-58
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Lovell, PJ
Bromidge, SM
Dabbs, S
Duckworth, DM
Forbes, IT
Jennings, AJ
King, FD
Middlemiss, DN
Rahman, SK
Saunders, DV
Collin, LL
Hagan, JJ
Riley, GJ
Thomas, DR
Citation: Pj. Lovell et al., A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970), J MED CHEM, 43(3), 2000, pp. 342-345
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gadre, A
Ham, P
Jones, GE
King, FD
Saunders, DV
Thewlis, KM
Vyas, D
Blackburn, TP
Holland, V
Kennett, GA
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Authors:
Bromidge, SM
Brown, AM
Clarke, SE
Dodgson, K
Gager, T
Grassam, HL
Jeffrey, PM
Joiner, GF
King, FD
Middlemiss, DN
Moss, SF
Newman, H
Riley, G
Routledge, C
Wyman, P
Citation: Sm. Bromidge et al., 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist, J MED CHEM, 42(2), 1999, pp. 202-205